Most Read Articles
Audrey Abella, 15 May 2020
In adults with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy (direct oral anticoagulant [DOAC] + P2Y12 inhibitor) reduces the risk of bleeding compared with triple therapy (vitamin K antagonist [VKA] + DAPT* [aspirin and P2Y12 inhibitor]), a meta-analysis has shown. However, its effects on the risks of mortality and ischaemic endpoints** remain unclear.
09 May 2020
Use of aspirin during the implantation window of the menstrual cycle appears to increase fecundability, reveals a recent study.
31 Mar 2020
When treating fibromyalgia patients with low-dose naltrexone, the 4.5-mg dose appears to be a good choice, according to a recent study.
Pearl Toh, 11 Jun 2019
The novel antibody-drug conjugate enfortumab vedotin showed promising clinical activity in patients with advanced and metastatic urothelial cancer for whom there is a high unmet need, according to the EV-201 study presented at the ASCO 2019 Meeting.

Systematic medication therapy management improves CMR completion rate in community pharmacy

08 Nov 2019
Pharmacists’ dual identity of the community they serve: A patient in need of professional care is also a paying customer who sustain the business.

Implementing a systematic approach for medication therapy management (MTM) in a community pharmacy setting may help improve the completion rate of a comprehensive medication review (CMR), suggests a recent study.

The investigators sought to determine how implementing a systematic MTM process impacted CMR completion rates in this process improvement pilot, which included four grocery store-based community pharmacy sites.

Site staff underwent training on a systematic process to integrate OutcomesMTM opportunities into their pharmacy workflow. Technicians prepared MTM paperwork, including a standardized CMR worksheet, which is used by pharmacists to deliver the service at the counsel window.

The change in CMR completion rate from pre- to postimplementation, with each site serving as its own control, was the primary outcome. Secondary outcomes included change in targeted intervention programme (TIP) completion rate and survey results assessing barriers and feasibility.

An improvement was observed in the mean completion rate of CMR from 2.7±5.4 percent to 23.2±7.7 percent (p<0.10). The mean TIP completion rate also improved from 3.4±4.2 percent to 24.9±19.2 percent (p<0.10) pre- to postimplementation.

In addition, survey results revealed that pharmacists were satisfied with the systematic approach. The most significant barriers were as follows: documentation, claim submission and time spent contacting prescribers.

This study, however, had certain limitations, such as its small sample size. Thus, the results and process may not be generalizable to other sites, according to the investigators.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 15 May 2020
In adults with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy (direct oral anticoagulant [DOAC] + P2Y12 inhibitor) reduces the risk of bleeding compared with triple therapy (vitamin K antagonist [VKA] + DAPT* [aspirin and P2Y12 inhibitor]), a meta-analysis has shown. However, its effects on the risks of mortality and ischaemic endpoints** remain unclear.
09 May 2020
Use of aspirin during the implantation window of the menstrual cycle appears to increase fecundability, reveals a recent study.
31 Mar 2020
When treating fibromyalgia patients with low-dose naltrexone, the 4.5-mg dose appears to be a good choice, according to a recent study.
Pearl Toh, 11 Jun 2019
The novel antibody-drug conjugate enfortumab vedotin showed promising clinical activity in patients with advanced and metastatic urothelial cancer for whom there is a high unmet need, according to the EV-201 study presented at the ASCO 2019 Meeting.